Target
Tyrosine-protein kinase JAK2
Ligand
BDBM325501
Substrate
n/a
Meas. Tech.
JAK2 Inhibition Assay
IC50
<10±n/a nM
Citation
 Allen, SBoys, MLChicarelli, MJFell, JBFischer, JPGaudino, JHicken, EJHinklin, RJKraser, CFLaird, ERobinson, JETang, TPBurgess, LERieger, RAPheneger, JSatoh, YLeftheris, KRaheja, RKBennett, BL 4,6-substituted-pyrazolo[1,5-a]pyrazines as Janus kinase inhibitors US Patent  US10730880 Publication Date 8/4/2020 
Target
Name:
Tyrosine-protein kinase JAK2
Synonyms:
JAK-2 | JAK2 | JAK2_HUMAN | Janus kinase 2 | Janus kinase 2 (JAK2) | Janus kinase 2 (a protein tyrosine kinase)
Type:
Protein
Mol. Mass.:
130684.68
Organism:
Homo sapiens (Human)
Description:
O60674
Residue:
1132
Sequence:
MGMACLTMTEMEGTSTSSIYQNGDISGNANSMKQIDPVLQVYLYHSLGKSEADYLTFPSGEYVAEEICIAASKACGITPVYHNMFALMSETERIWYPPNHVFHIDESTRHNVLYRIRFYFPRWYCSGSNRAYRHGISRGAEAPLLDDFVMSYLFAQWRHDFVHGWIKVPVTHETQEECLGMAVLDMMRIAKENDQTPLAIYNSISYKTFLPKCIRAKIQDYHILTRKRIRYRFRRFIQQFSQCKATARNLKLKYLINLETLQSAFYTEKFEVKEPGSGPSGEEIFATIIITGNGGIQWSRGKHKESETLTEQDLQLYCDFPNIIDVSIKQANQEGSNESRVVTIHKQDGKNLEIELSSLREALSFVSLIDGYYRLTADAHHYLCKEVAPPAVLENIQSNCHGPISMDFAISKLKKAGNQTGLYVLRCSPKDFNKYFLTFAVERENVIEYKHCLITKNENEEYNLSGTKKNFSSLKDLLNCYQMETVRSDNIIFQFTKCCPPKPKDKSNLLVFRTNGVSDVPTSPTLQRPTHMNQMVFHKIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAWAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYEDRHQLPAPKWAELANLINNCMDYEPDFRPSFRAIIRDLNSLFTPDYELLTENDMLPNMRIGALGFSGAFEDRDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNMAG
  
Inhibitor
Name:
BDBM325501
Synonyms:
US10189845, Example 163A | US10189845, Example 164B | US10730880, Example 164
Type:
Small organic molecule
Emp. Form.:
C22H27N7O2
Mol. Mass.:
421.4955
SMILES:
CCC(CC)n1cc(cn1)-c1nc(cn2nccc12)-c1cnn(c1)C1C[C@@](O)(CO)C1 |r,wU:26.30,wD:26.31,(-.1,19.14,;-.87,17.8,;-.1,16.47,;1.44,16.47,;2.21,17.8,;-.87,15.13,;-.39,13.67,;-1.64,12.77,;-2.88,13.67,;-2.41,15.13,;-1.64,11.23,;-.3,10.46,;-.3,8.92,;-1.64,8.15,;-2.97,8.92,;-4.44,8.44,;-5.34,9.69,;-4.44,10.93,;-2.97,10.46,;1.03,8.15,;2.49,8.62,;3.4,7.38,;2.49,6.13,;1.03,6.61,;2.89,4.64,;2.12,3.31,;3.46,2.54,;5,2.54,;3.85,1.05,;5.34,.65,;4.23,3.87,)|
Structure:
Search PDB for entries with ligand similarity: